ClassID:

91898

C07C57/62 - CPC Classification

Classification description:

Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings and other rings

Recent Application in this class:
#1
20210101861
2021-04-08

NOVEL REXINOID COMPOUNDS AND METHODS OF USING REXINOID COMPOUNDS FOR TREATING METABOLIC DISORDERS AND CANCER

#2
20210053938
2021-02-25

Compounds containing carbon-carbon linker as GPR120 agonists

#3
20190375702
2019-12-12

Process for the synthesis of 1-aryl-1-trifluoromethylcyclopropanes

#4
20180201565
2018-07-19

Rexinoid compounds and methods of using rexinoid compounds for treating metabolic disorders and cancer

#5
20180030031
2018-02-01

Compounds containing carbon-carbon linker as GPR120 agonists

#6
20170313668
2017-11-02

Methods and compositions related to retinoid receptor-selective pathway

#7
20170182046
2017-06-29

Therapeutic compounds

#8
20160090531
2016-03-31

Liquid crystal composition and liquid crystal display device

#9
20150266842
2015-09-24

Methods and compositions related to a retinoid receptor-selective pathway

#10
20150183737
2015-07-02

COMPOSITIONS AND METHODS FOR SUBSTRATE-SELECTIVE INHIBITION OF ENDOCANNABINOID OXYGENATION

#11
20150133547
2015-05-14

METHOD AND COMPOSITION FOR TREATING GLAUCOMA

#12
20150038731
2015-02-05

Process for preparing carboxylic acids

#13
20140343079
2014-11-20

Therapeutic compounds

#14
20120157696
2012-06-21

Method of making indeno-fused naphthol materials

#15
20120029202
2012-02-02

Process for the Preparation of 5-Substituted 3-Aryl-3-(trifluoromethyl)-3,4-dihydro-2H-pyrroles

#16
20110288175
2011-11-24

1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases

#17
20110092554
2011-04-21

1,3,5 TRI-SUBTITUTED BENZENES FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISORDERS

#18
20100261772
2010-10-14

Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators

#19
20100204199
2010-08-12

Cyclic 11-beta hydroxysteroid dehydrogenase type 1 inhibitors

#20
20100099768
2010-04-22

1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases

#21
20090312426
2009-12-17

Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid

#22
20090270396
2009-10-29

Therapeutic compounds

#23
20080234249
2008-09-25

Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors

#24
20080167360
2008-07-10

Cycloalkylidene compounds as selective estrogen receptor modulators

#25
20070259836
2007-11-08

Therapeutic cyclopentane derivatives

#26
20070244155
2007-10-18

Bicyclic carboxylic acid derivatives useful for treating metabolic disorders

#27
20070225520
2007-09-27

Stereoselective synthesis of a 4,4-disubstituted cyclohexanepropanoic acid

#28
20070060752
2007-03-15

1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases